Xie Y, Zhou T, Li X, Zhao K, et al. Targeting ESE3/EHF with Nifurtimox inhibits CXCR2+ neutrophil infiltration and overcomes pancreatic cancer resistance to chemotherapy and immunotherapy. Gastroenterology 2024 Mar 14:S0016-5085(24)00291.
PMID: 38492894